Monte Rosa Therapeutics, Inc.
Biotechnology company · Boston, Massachusetts, United States · Nasdaq: GLUE
Monte Rosa Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker GLUE. It has reported private securities offerings to the US SEC, most recently $95 million sold in a notice filed in 2021.
Monte Rosa Therapeutics at a glance
What does Monte Rosa Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $95 million sold (2021).
Frequently asked questions about Monte Rosa Therapeutics
Where is Monte Rosa Therapeutics headquartered?
Monte Rosa Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Monte Rosa Therapeutics do?
Monte Rosa Therapeutics, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Monte Rosa Therapeutics a public company?
Yes. Monte Rosa Therapeutics, Inc. trades on Nasdaq under the ticker GLUE.
When was Monte Rosa Therapeutics founded?
The earliest incorporation on record for Monte Rosa Therapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Elucid Bioimaging Inc.Boston, Massachusetts, United States
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.